Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Natalizumab Use In Multiple Sclerosis: A Real World Evidence (Rwe) Analysis of Its Impact on Nhs Resources In England.
Small molecules with anti-inflammatory properties in clinical development.
[Axonal Regeneration-related Molecules as Biomarkers for Multiple Sclerosis].
The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
Nervous system involvement of connective tissue disease: mechanisms and diagnostic approach.
Diagnostic accuracy of current sonographic criteria for the detection of outflow abnormalities in the internal jugular veins.
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage.
In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.
Immune Rebound: Multiple Sclerosis after Treatment of Cushing's Disease.
[The treatment by expanded ex vivo autologous regulatory T-cells CD4+CD25+FoxP3+CD127low restores the balance of immune system in patients with remitting-relapsing multiple sclerosis].
Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease.
Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines.
Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling.
Ultraviolet radiation, vitamin D and multiple sclerosis.
Prevalence of neuropathic pain in early multiple sclerosis.
Preliminary Evidence of Increased Hippocampal Myelin Content in Veterans with Posttraumatic Stress Disorder.
The potential role of subclinical Bordetella Pertussis colonization in the etiology of multiple sclerosis.
Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.
Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol - studies in BV-2 microglia and encephalitogenic T cells.
Reversed takotsubo cardiomyopathy in a patient with new-onset multiple sclerosis: Cause, link, or just coincidence?
Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis.
Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
Does ability to walk reflect general functionality in inflammatory neuropathies?
Neuroprotective Effects of Endurance Exercise against High Fat Diet-Induced Hippocampal Neuroinflammation.
Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
667
668
669
670
671
672
673
674
675
…
next ›
last »